SCHEMBL8327595

SCHEMBL8327595

COc1ccc(CN2CCCCC2)cc1F

nearest known ligand 0.68

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.66
HTT P42858 2/20 0.66
DRD4 P21917 5/20 0.59
SIGMAR1 Q99720 5/20 0.58
GAA P10253 1/20 0.56
TMEM97 Q5BJF2 3/20 0.56
LMNA P02545 1/20 0.54
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16825126 0.98 ALDH1A1 (0.64) ALDH1A1HTTDRD4SIGMAR1GAA
SCHEMBL8325210 0.98 ALDH1A1 (0.63) ALDH1A1HTTDRD4SIGMAR1GAA
SCHEMBL13559777 0.86 CHKA (0.56) ALDH1A1DRD4SIGMAR1TMEM97
SCHEMBL28191613 0.85 GAA (0.66) ALDH1A1SIGMAR1GAAMAPK1
SCHEMBL2733863 0.85 CYP1A2 (0.54) ALDH1A1HTTDRD4SIGMAR1TMEM97
SCHEMBL23179563 0.84 HTR7 (0.66) DRD4SIGMAR1TMEM97
SCHEMBL16884151 0.83 GAA (0.63) ALDH1A1SIGMAR1GAAMAPK1
SCHEMBL17946120 0.82 DRD4 (0.55) ALDH1A1DRD4SIGMAR1TMEM97
SCHEMBL30815930 0.82 DRD4 (0.55) ALDH1A1DRD4SIGMAR1TMEM97
SCHEMBL27543073 0.81 GAA (0.57) ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3083584-A1 NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS Sunshine Lake Pharma Co., Ltd. (CN) 2016-10-26 EP disclosed
WO-2015090232-A1 NITROGENOUS HETEROCYCLIC DERIVATIVES AND THEIR APPLICATION IN DRUGS SUNSHINE LAKE PHARMA CO., LTD. (CN) 2015-06-25 WO disclosed
EP-1592426-B1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2007-12-19 EP disclosed
WO-2004069256-A1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-08-19 WO disclosed